|
Volumn 68, Issue 8, 2013, Pages 780-781
|
Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CD20 ANTIGEN;
CYCLOPHOSPHAMIDE;
METHYLPREDNISOLONE;
PREDNISOLONE;
RITUXIMAB;
ADULT;
ALLERGIC PNEUMONITIS;
ARTICLE;
CASE REPORT;
CD3+ T LYMPHOCYTE;
COUGHING;
DETERIORATION;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DYSPNEA;
EXERCISE TOLERANCE;
FEMALE;
FORCED VITAL CAPACITY;
HIGH RESOLUTION COMPUTER TOMOGRAPHY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG BIOPSY;
LUNG DIFFUSION CAPACITY;
LUNG FIBROSIS;
PRIORITY JOURNAL;
HYPERSENSITIVITY PNEUMONITIS;
INTERSTITIAL FIBROSIS;
ALVEOLITIS, EXTRINSIC ALLERGIC;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTIGENS, CD20;
BIOPSY;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOLOGIC FACTORS;
LUNG;
MIDDLE AGED;
TOMOGRAPHY, X-RAY COMPUTED;
VITAL CAPACITY;
|
EID: 84879974781
PISSN: 00406376
EISSN: 14683296
Source Type: Journal
DOI: 10.1136/thoraxjnl-2013-203265 Document Type: Article |
Times cited : (47)
|
References (5)
|